MENU

CureVac (CVAC) Ownership - Who owns CureVac?

Profile

Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
639.29M
P/E Ratio
N/A
Total Cash
206.25M
Projected Growth
N/A
Total Debt
39.04M
Revenue
65.86M
Risk (Beta)
1.79
Dividend Yield
N/A
Total Cash/Share
0.92
Total Debt/Equity
N/A
Revenue/Share
0.32 USD as % of share price

Fundamentals

CVAC
Capitalization
639M
P/E Ratio
N/A
Risk (Beta)
1.79
Dividend Yield
N/A
Total Cash
206M
Total Cash/Share
0.92
Total Debt
39M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.32%
Revenue
65.9M
ROE
N/A
Book Value
377M
P/B Ratio
1.54
Cash Flow
N/A
Earnings
-1.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
26.9M
Current Ratio
2.29
Current Revenue Per Employee
13123.64
Dividends Per Share - Security
N/A
EBITDA
-254.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
-182.09
Revenue To Assets
-38.24
Shares Held By Institutions
77.7M
Shares Outstanding - Current
224M
Total Liabilities
180M
Total Volume MTD
N/A
Value
1
Gain YTD
-32.304
View a ticker or compare two or three
CVAC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com